Reply to: Enfortumab Vedotin: A Promising Therapy for Head and Neck Cancer With Potential Links to Human Papillomavirus

J Clin Oncol. 2025 May;43(13):1611-1612. doi: 10.1200/JCO-25-00028. Epub 2025 Feb 19.
No abstract available